Evaluation of an Investigational Multifocal Lens
Public ClinicalTrials.gov record NCT02223754. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT02223754
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Johnson & Johnson Vision Care, Inc.
- Industry
- Enrollment
- 371 participants
Conditions and interventions
Conditions
Interventions
- etafilcon A Device
- lotrafilcon B Device
Device
Eligibility (public fields only)
- Age range
- 40 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2014
- Primary completion
- Oct 31, 2014
- Completion
- Oct 31, 2014
- Last update posted
- Jun 18, 2018
2014
United States locations
- U.S. sites
- 20
- U.S. states
- 13
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Montgomery | Alabama | 36109 | — |
| Not listed | Mission Viejo | California | 92691 | — |
| Not listed | Jacksonville | Florida | 32205 | — |
| Not listed | Jacksonville | Florida | 32250 | — |
| Not listed | Orange Park | Florida | 32065 | — |
| Not listed | Saint Augustine | Florida | 32092 | — |
| Not listed | Tallahassee | Florida | 32308 | — |
| Not listed | Tampa | Florida | 33625 | — |
| Not listed | Winter Park | Florida | 32792 | — |
| Not listed | Roswell | Georgia | 30076 | — |
| Not listed | Pittsburg | Kansas | 66762 | — |
| Not listed | East Lansing | Michigan | 48823 | — |
| Not listed | Vestal | New York | 13850 | — |
| Not listed | Denver | North Carolina | 28037 | — |
| Not listed | Powell | Ohio | 43065 | — |
| Not listed | Springfield | Ohio | 45503 | — |
| Not listed | Warwick | Rhode Island | 02888 | — |
| Not listed | Memphis | Tennessee | 38119 | — |
| Not listed | Tyler | Texas | 75701 | — |
| Not listed | Salem | Virginia | 24153 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02223754, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 18, 2018 · Synced Apr 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02223754 live on ClinicalTrials.gov.